PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New research advances understanding of cancer risk in gene therapies

Researchers have discovered that “cell competition” following gene therapy results in the accumulation of stem cells with genetic mutations which make them grow faster

New research advances understanding of cancer risk in gene therapies
2023-11-16
(Press-News.org) Medical research has shown promising results regarding the potential of gene therapy to cure genetic conditions such as sickle cell disease and the findings of this study, published in Nature Medicine, offer important new insights into processes happening in the body after treatment.

The present study looked at samples from six patients with sickle cell disease who were undergoing gene therapy as part of a major clinical trial at Boston Children’s Hospital. The research brought together an international team of experts, to take a closer look at the genetic changes in the stem cells of patients before and after gene therapy and compare the cells that were modified with the therapy to those that weren't.

The study highlights the importance of long-term and in-depth monitoring of stem cell samples from patients with genetic conditions to track mutations that could lead to blood cancer, the researchers say. 

Co-senior author of the study Professor David Kent from the Department of Biology and York Biomedical Research Institute said: "Think of the gene therapy process like clearing a forest and planting new seedlings.  If you imagine that some seedlings are red and some are green, then the ‘selection’ we are observing is akin to having the forest regrow red trees preferentially.

“Our research indicates that gene therapy imposes a selection on different blood stem cells, the ‘seed’ cells of our blood and immune system. After gene therapy, the treatment might favour growth of stem cells with certain mutations, and this in turn could potentially lead to expansion of blood cells containing these mutations. In other settings, such expansions have been associated with development of blood cancers, particularly in older individuals, but the relationship of this study’s findings to the risk of blood cancers is not yet fully understood.”

The researchers used new technologies in genome science that allow blood cells to be tracked and compared in patients, a new approach which could substantially influence gene therapy trials in the future.

Co-senior author of the study Dr David Williams from Boston Children’s Hospital and Harvard Medical School noted: “Gene therapy holds immense potential to cure genetic conditions such as sickle cell disease, and understanding how the process influences blood stem cell growth in the long run is crucial for safety. Notably, our study revealed that younger patients, with fewer genetic mutations in their stem cells, didn't exhibit strong signs of mutations post-therapy. This suggests that treating patients with gene therapy at a younger age could be both safer and more effective, but substantial work needs to be done to test this formally."

Sickle cell disease, an inherited genetic disorder, alters the natural round and flexible shape of red blood cells into a sickle or crescent shape, leading to severe health issues and putting patients at higher risk of developing blood cancer. Though approximately 100 million people carry the sickle cell trait worldwide, the disease only occurs if a child inherits the trait from both parents. In regions where the trait is prevalent, such as parts of sub-Saharan Africa, up to 20 percent of the population can be affected.

However, recent advances in gene therapy offer hope. This innovative approach involves modifying a patient's own stem cells outside the body, correcting the faulty gene responsible for the abnormal cell shape. These corrected cells are reintroduced into the patient, aiming to replace the problematic cells with healthy, normal-shaped ones.

The study, funded by the Bill and Melinda Gates Foundation, reveals that the gene therapy treatment itself is not the likely cause of new DNA mutations in blood stem cells. Instead, the process of genetically modifying these stem cells outside the body and re-transplanting them back into the patient makes blood stem cells that already have these mutations more prominent, thereby increasing their influence on the blood and immune systems.

The research team say the findings also suggest that younger patients may have acquired fewer stem cell mutations in their lifetime, which may inform the optimal age for gene therapies in this and other diseases in the future.

Co-lead author of the paper, Dr Alyssa Cull from the Department of Biology and York Biomedical Research Institute, emphasised the need for further research: "We now require more in-depth studies to uncover the precise connections behind specific mutations and the gene therapy procedure. There are pressing questions regarding how we can refine gene therapy to avoid stem cells that might contain mutations that affect blood cell growth. Determining whether mutations within a sample of cells are dangerous in the long run remains challenging though and substantial further research is needed.”

Co-lead author Michael Spencer-Chapman from the Wellcome Sanger Institute echoes the need for longer term follow-up of patients saying: “Our research revealed that both gene-therapy modified and unaltered stem cells from sickle cell patients sometimes contained cancer-associated mutations leading to accelerated growth through the gene therapy procedure. Continuously tracking these mutations and gaining a deeper understanding of these processes will profoundly impact the future well-being of sickle cell patients around the world."

Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease is published in Nature Medicine

END

[Attachments] See images for this press release:
New research advances understanding of cancer risk in gene therapies New research advances understanding of cancer risk in gene therapies 2 New research advances understanding of cancer risk in gene therapies 3

ELSE PRESS RELEASES FROM THIS DATE:

A small molecule blocks aversive memory formation, providing a potential treatment target for depression

A small molecule blocks aversive memory formation, providing a potential treatment target for depression
2023-11-16
Depression is one of the most common mental illnesses in the world, but current anti-depressants have yet to meet the needs of many patients. Neuroscientists from City University of Hong Kong (CityU) recently discovered a small molecule that can effectively alleviate stress-induced depressive symptoms in mice by preventing aversive memory formation with a lower dosage, offering a new direction for developing anti-depressants in the future. “Depression affects millions of individuals worldwide, necessitating more effective treatments. Conventional methods, such as drug therapy with delayed onset of action and psychotherapy, have limitations in yielding satisfactory ...

Plants that survived dinosaur extinction pulled nitrogen from air

Plants that survived dinosaur extinction pulled nitrogen from air
2023-11-16
DURHAM, N.C. -- Once a favored food of grazing dinosaurs, an ancient lineage of plants called cycads helped sustain these and other prehistoric animals during the Mesozoic Era, starting 252 million years ago, by being plentiful in the forest understory. Today, just a few species of the palm-like plants survive in tropical and subtropical habitats. Like their lumbering grazers, most cycads have gone extinct. Their disappearance from their prior habitats began during the late Mesozoic and continued into the early Cenozoic Era, punctuated by the cataclysmic asteroid impact and volcanic activity that mark the K-Pg boundary 66 million years ago. However, unlike the dinosaurs, somehow a few groups ...

The mind’s eye of a neural network system

The mind’s eye of a neural network system
2023-11-16
WEST LAFAYETTE, Ind. – In the background of image recognition software that can ID our friends on social media and wildflowers in our yard are neural networks, a type of artificial intelligence inspired by how own our brains process data. While neural networks sprint through data, their architecture makes it difficult to trace the origin of errors that are obvious to humans — like confusing a Converse high-top with an ankle boot — limiting their use in more vital work like health care image analysis or research. A new tool developed at Purdue University makes finding those errors as simple as spotting mountaintops from an airplane.   “In a sense, if a neural ...

Study finds motorist disorientation syndrome is not only caused by vestibular dysfunction

2023-11-16
Amsterdam, November 16, 2023 – A large case series aimed at understanding the factors underlying Motorist Disorientation Syndrome (MDS) has found that patients experience severe, consistent symptoms comparable to vestibular migraine. Previously there has been speculation that underlying peripheral vestibular hypofunction, when the inner ear part of the balance system is not working properly, contributes to this presentation. However, vestibular deficits were not a consistent feature in the patients studied. The findings have been published in the Journal of Vestibular Research. In ...

Rabies virus variants from marmosets are found in bats

Rabies virus variants from marmosets are found in bats
2023-11-16
Rabies virus variants closely related to variants present in White-tufted marmosets (Callithrix jacchus) have been detected in bats in Ceará state, Northeast Brazil.  Rabies is a deadly disease for humans. Its emergence in distinct wildlife species is a potential source of human infection and hence a public health concern. Marmosets are common in forests and conservation units throughout Brazil. In or near urban areas, they are often captured as pets and later abandoned. They have been linked ...

How a mutation in microglia elevates Alzheimer’s risk

How a mutation in microglia elevates Alzheimer’s risk
2023-11-16
A rare but potent genetic mutation that alters a protein in the brain’s immune cells, known as microglia, can give people as much as a three-fold greater risk of developing Alzheimer’s disease. A new study by researchers in The Picower Institute for Learning and Memory at MIT details how the mutation undermines microglia function, explaining how it seems to generate that higher risk. “This TREM2 R47H/+ mutation is a pretty important risk factor for Alzheimer’s disease,” said study lead author Jay Penney, a former postdoc in the MIT lab of Picower Professor Li-Huei ...

International team uses Insilico Medicine’s AI platform to find dual targets for aging and cancer

International team uses Insilico Medicine’s AI platform to find dual targets for aging and cancer
2023-11-16
An international research team is the first to use artificial intelligence (AI) analysis to identify dual-purpose target candidates for the treatment of cancer and aging, the most promising of which was experimentally validated. The findings were published in the journal Aging Cell.  Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and clinical stage AI-driven drug discovery company Insilico Medicine used Insilico’s AI target discovery engine, PandaOmics, to analyze transcriptomic data derived from ...

New therapeutic strategy to reduce neuronal death in amyotrophic lateral sclerosis

New therapeutic strategy to reduce neuronal death in amyotrophic lateral sclerosis
2023-11-16
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. A study by the University of Barcelona has designed a potential therapeutic strategy to tackle this pathology that has no treatment to date. It is a molecular trap that prevents one of the most common genetic ALS-causing peptide compounds, the Poly-GR dipeptide, from causing its toxic effects in the body. The results show that this strategy reduces the death of neurons in patients and in an animal model (vinegar flies) of the disease.   The first authors of this international research study published in the journal Science Advances are ...

Breakthrough in bladder cancer research

2023-11-16
After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of not just one, but two studies have been presented at the European Society for Medical Oncology (ESMO) conference in Madrid. The outcomes of these studies are going to revolutionize the landscape of bladder cancer treatment. Traditionally, cisplatin-based chemotherapy has been the standard treatment for bladder cancer patients who are able to tolerate this drug. However, responses have been limited, and durable outcomes rare. Over the past years, two phase-3 clinical trials studied the effects ...

Study: Temperature variability reduces nesting success

Study: Temperature variability reduces nesting success
2023-11-16
Ithaca, N.Y.—Many songbirds are nesting earlier in spring because of warmer temperatures brought about by climate change. But the shift brings another danger that is especially deadly for nestlings: greater exposure to temperature variability in the form of cold snaps and heat waves. Such extremes result in more nest failures. These findings come from a Cornell Lab of Ornithology study just published in the journal Nature Communications.   "When we talk about temperature changes, the focus is mostly on averages," said co-lead author Conor Taff, a researcher in Cornell University's ...

LAST 30 PRESS RELEASES:

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

New light on toxicity of Bluefin tuna

Menopause drug reduces hot flashes by more than 70%, international clinical trial finds

FGF21 muscle hormone associated with slow ALS progression and extended survival

Hitting the right note: The healing power of music therapy in the cardiac ICU

Cardiovascular disease risk rises in Mexico, despite improved cholesterol control

Flexible optical touch sensor simultaneously pinpoints pressure strength and location

Achalasia diagnosis simplified to AI plus X-ray

PolyU scholars pioneer smart and sustainable personal cooling technologies to address global extreme heat

NIH grant aims for childhood vaccine against HIV

Menstrual cycle and long COVID: A relation confirmed

WMO report on global water resources: 2024 was characterized by both extreme drought and intense rainfall

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

Thermal trigger

SNU materials science and engineering team identifies reconstruction mechanism of copper alloy catalysts for CO₂ conversion

[Press-News.org] New research advances understanding of cancer risk in gene therapies
Researchers have discovered that “cell competition” following gene therapy results in the accumulation of stem cells with genetic mutations which make them grow faster